| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Donald G. Fell last filed a Form 4 in June 2025, as Director at SCNX. The filings on record cover 2 companies. Donald G. Fell's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Historically, Donald G. Fell's trades have earned a below-average insider score of 31/100 across 4 rated trades. Over a 12-month horizon, none of those trades were profitable, with an average 12-month return of -62.5%.
At the last filing, the largest reported position was 75,664 shares of SCNX. The SCNX filings lean toward selling, a net 4,407 shares.
Donald G. Fell has 11 Form 4 filings on record from March 2017 to June 2025, across 2 companies: Director at Aspire Biopharma (ASBP), 2025; Director at Scienture (SCNX), 2017–2022.
The 34 reported transactions were 13 gifts, 12 open-market sales, 4 open-market purchases and 3 stock awards, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 3 purchases worth about $12K and 2 sales worth about $7K.
The largest open-market purchase was 20,000 shares of ASBP at an average $0.39 on June 5, 2025, about $8K. Twelve months later ASBP was down 61%.
The largest open-market sale was 7,407 shares of SCNX at an average $0.56 on October 8, 2019, about $4K.
Shares as reported in the last Form 4 for each company; the most recent is from June 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 5, 2025 | ASBP Aspire Biopharma Holdings, Inc. | Director | Buy | 20,000 | $0.39 | $7,800.00 | New | +72.3% | -60.7% | |
| Aug 25, 2022 | SCNX Scienture Holdings, Inc. | Director | Buy | 1,500 | $1.08 | $1,620.00 | +7.6% | -44.5% | -57.2% | |
| May 12, 2022 | SCNX Scienture Holdings, Inc. | Director | Buy | 2,000 | $1.26 | $2,520.00 | +11.3% | +18.7% | -69.4% | |
| Dec 14, 2020 | SCNX Scienture Holdings, Inc. | - | Sell | 500 | $5.30 | $2,650.00 | -5.6% | - | - | |
| Oct 8, 2019 | SCNX Scienture Holdings, Inc. | Director | Sell | 7,407 | $0.56 | $4,175.78 | -82.4% | - | - |